West Pharmaceutical targets 2-3% organic sales growth for 2025, highlights GLP-1 market expansion
Discover key insights from West Pharmaceutical Services' Q4 2024 earnings call, highlighting growth in GLP-1 elastomers, biologics, and HVP components.
StockStory.org on MSN2d
ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...
ANI Pharmaceuticals: More Than Just A Generics Company
ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...
The new rules make it harder to get Mounjaro... here's my plan to make sure I NEVER regain the weight I lost using the jabs
Until this week, everything was going marvellously. My size 12 jeans were gaping at the waistline, and I could slip into a ...